Business news – Page 79
-
Business
Drug companies rapped for anticompetitive behaviour
Italian authorities demand €1.2 billion in damages from Roche, Novartis and Pfizer
-
Feature
Triple-stranded success story
Tom Brown is our Entrepreneur of the Year. He tells Sarah Houlton the secrets of his success
-
Business
Nano risk register not necessary, says BASF
Reach covers the relevant information, and a register risks attracting unwarranted stigma
-
Opinion
Messy megamergers
Big company buyouts are more about immediate gains and rarely consider the impact on research, says Derek Lowe
-
Business
Chinese-made DNA sequencer aims to challenge foreign dominance
Domestic instrument pitching for a slice of the world’s fastest growing genome sequencing market
-
Business
Boehringer to settle blood thinner drug suits for $650m
Company confident in drug safety but says court cases are too risky
-
Business
Time called on Pfizer–AstraZeneca deal
Pfizer could make a fresh approach after six months under City takeover rules
-
Feature
Reaching out
Andy Extance surveys how pharma uses outsourcing in a variety of different ways
-
Business
Mitsui continues reinvention efforts with two deals
Japanese firm drops organic acids in favour of lens materials
-
Business
Novartis enhances its focus with eyecare deal
Swiss firm buys rights to wet AMD drug from Ophthotech for up to $1bn
-
Business
AstraZeneca refuses Pfizer’s ‘final’ offer
Pfizer pledges not to make hostile bid direct to shareholders
-
Business
Lilly protests $450m Brazilian fine
Firm says chemicals employees were allegedly exposed to were never used at site
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes
-
Business
Pfizer presses hard for AstraZeneca deal
Executives face down international controversy over tax schemes and previous post-merger record
-
Business
Solvay-Ineos PVC deal passes European approval
Firms required to divest plants to maintain competition
-
Business
Bayer wins race to buy Merck & Co consumer care
$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
-
Business
UK Lords urge government to take lead on fracking
Regulations holding back shale gas exploration, report says
-
Careers
Science within Reach
Charlotte Ashley-Roberts explains what the Reach regulations could mean for you and your role